Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03674424
Title Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers (AURA Trial) (AURA)
Acronym AURA
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jules Bordet Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | BEL

Facility Status City State Zip Country Details
UZAntwerpen Edegem Antwerpen 2650 Belgium Details
Centre Hospitalier Universitaire et Psychiatrique de Mons-Borinage Mons Hainaut 7000 Belgium Details
Institut Jules Bordet Brussels 1000 Belgium Details
Grand Hôpital de Charleroi Gilly 6000 Belgium Details
CHU de Liège Sart Tilman Liège 4000 Belgium Details
CHU Namur - Sainte Elisabeth Namur 5000 Belgium Details
Centre Oscar Lambret Lille 59000 France Details
Groupe Hospitalier Paris Saint Joseph Paris 75014 France Details
Hôpital Saint Louis Paris 75475 France Details
Hôpitaux universitaires de Strasbourg Strasbourg 67091 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field